Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
2
Atlanta Ventures, Y Combinator
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
App Store
4.9 ★
159 ratings
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Framewise Health creates clinically validated demonstration videos for patients. Personalized to each patient, reviewed by clinicians…
Protyon51-200 employees
Supporting the clinical decision-making process to choose the best available therapy for patients.
xCuresSeries B $46M · 3 mo ago • Founded 2018 • 11-50 employees
XCures is the Clinical Clarity Engine for healthcare, assembling and structuring patient medical records into decision-ready data.
ClearstepVenture round $4.2M · 20 mo ago • Founded 2018 • 51-200 employees
Clearstep's clinical AI agents automate patient triage, scheduling, and care navigation, built on gold-standard nurse protocols, integrated…
EvidenceCareVenture round $5.9M · 5 yr ago • 51-200 employees • 1 role
Together, EvidenceCare and Agathos will address one of healthcare’s biggest challenges: reducing unwarranted clinical variation.
Medigram1-10 employees
Medigram builds governed decision infrastructure for high-stakes clinical AI. Darwin is its governed decision platform, independently…

Overview

We provide clinical pharmacist-reviewed, AI-generated drug information, so your clinical pharmacists can spend more time with patients.

News

News outofpocket.health 6 months ago
Clinical Pharmacists, Generative AI, and InpharmD Out-Of-Pocket
Going under the hood of a generative AI product
Read more
Report
News Atlanta Ventures 3 years ago
Why We Invested in InpharmD
We are excited to announce our latest investment in InpharmD
Read more
Report
News Qlarant 3 years ago
Qlarant Capital Becomes Investor in InpharmD
Qlarant Capital announced the addition of InpharmD to their growing investment portfolio of burgeoning health care solutions companies.
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.